Drug: Atridox

The ATRIDOX (doxycycline hyclate) ® product is a subgingival controlled-release product composed of a two syringe mixing system. Syringe A contains 450 mg of the ATRIGEL® Delivery System, which is a bioabsorbable, flowable polymeric formulation composed of 36.7% poly(DLlactide) (PLA) dissolved in 63.3% N-methyl-2-pyrrolidone (NMP). Syringe B contains 50 mg of doxycycline hyclate which is equivalent to 42.5 mg doxycycline. The constituted product is a pale yellow to yellow viscous liquid with a concentration of 10% of doxycycline hyclate. Upon contact with the crevicular fluid, the liquid product solidifies and then allows for controlled release of drug for a period of 7 days. Doxycycline is a broad-spectrum antibiotic synthetically derived from oxytetracycline. The structural formula of doxycycline hyclate is:
Empirical Formula: (C22H24N2O8•HCI)2•C2H6O•H2O

Source: http://www.rxlist.com

In clinical trials involving a total of 1436 patients, adverse experiences from all causalities were monitored across treatment groups. In the Circulatory System category, 10 subjects (1.6%) in the ATRIDOX (doxycycline hyclate) ® group were reported as having “unspecified essential hypertension.” Only 1 subject (0.2%) in the Vehicle group, and none in the Scaling and Root Planing or Oral Hygiene groups were reported to have “unspecified essential hypertension.” In all cases, the event occurred anywhere from 13 to 134 days post treatment. There is no known association of oral administration of doxycycline with essential hypertension. Two patients in the polymer vehicle group and none in the ATRIDOX (doxycycline hyclate) ® group (0.2% for both groups combined) reported adverse events consistent with a localized allergic response. Sex, age, race and smoking status did not appear to be correlated with adverse events. The following table lists the incidence of treatment-emergent adverse events from all causalities, across all treatment groups, occurring in ≥ 1% of the entire study population. Body System Verbatim Terms Doxycycline
n=609 Vehicle
n=413 OH
n=204 SRP
n=210 Circulatory   High blood pressure 1.60% 0.20% 0.00% 0.00% Digestive   Gum discomfort, pain or soreness; loss of attachment; increased pocket depth 18.10% 23.00% 20.10% 21.00%   Toothache, pressure sensitivity 14.30% 14.30% 10.30% 18.10%   Periodontal abscess, exudate, infection, drainage, extreme mobility, suppuration 9.90% 10.90% 10.30% 8.60%   Thermal tooth sensitivity 7.70% 8.50% 4.40% 6.70%   Gum inflammation, swelling, sensitivity 4.10% 5.80% 5.40% 5.70%   Soft tissue erythema, sore mouth, unspecified pain 4.30% 5.30% 2.70% 6.20%   Indigestion, upset stomach, stomachache 3.60% 4.10% 2.90% 3.80%   Diarrhea 3.30% 2.40% 1.00% 1.00%   Tooth mobility, bone loss 2.00% 0.70% 0.50% 2.40%   Periapical abscess, lesion 1.50% 1.90% 1.00% 0.50%   Aphthous ulcer, canker sores 0.70% 1.70% 1.00% 1.40%   Fistula 0.80% 1.50% 1.50% 1.00%   Endodontic abscess, pulpitis 1.50% 1.50% 0.00% 0.50%   Jaw pain 1.10% 0.50% 1.00% 1.90%   Tooth loss 0.80% 1.50% 1.50% 0.00%   Bleeding gums 1.00% 0.70% 0.00% 2.40% Genitourinary   Premenstrual tension syndrome 4.40% 3.10% 2.50% 3.30% Ill-Defined Conditions   Headache 27.30% 28.10% 23.50% 23.80%   Cough 3.60% 6.10% 2.90% 2.40%   Sleeplessness 3.40% 1.50% 2.00% 2.90%   Body aches, soreness 1.60% 1.20% 1.50% 1.40%   Nausea and vomiting 1.80% 0.70% 2.50% 0.50%   Fever 1.00% 1.90% 1.00% 1.90% Injury & Poisoning   Broken tooth 5.10% 4.10% 4.90% 5.70% Mental   Tension headache 1.80% 0.70% 0.00% 1.00% Musculoskeletal   Muscle aches 6.40% 4.60% 4.90% 3.30%   Backache 3.60% 5.30% 2.50% 6.20%   Pain in arms or legs 1.50% 2.20% 2.00% 2.40%   Lower back pain 1.60% 1.70% 0.50% 2.90%   Neck pain 1.30% 1.70% 1.00% 1.90%   Shoulder pain 1.00% 1.00% 1.50% 1.00% Nervous System   Ear infection 1.60% 1.90% 2.00% 0.00% Respiratory    Common cold 25.50% 25.20% 18.10% 16.70%   Flu, respiratory 6.10% 9.00% 3.90% 6.70%   Stuffy head, post nasal drip, congestion 5.60% 7.70% 2.90% 4.80%   Sore throat 5.70% 6.50% 2.00% 3.30%   Sinus infection 5.30% 2.70% 1.00% 1.90%   Flu 2.80% 2.90% 2.90% 3.30%   Bronchitis 2.30% 1.90% 1.50% 1.00%   Allergies 1.00% 1.00% 1.00% 1.90% Skin & Subcutaneous Tissue   Skin infection or inflammation 1.30% 1.00% 1.00% 1.00% Read the Atridox (doxycycline hyclate) Side Effects Center for a complete guide to possible side effectsLearn More »

Source: http://www.rxlist.com

ATRIDOX (doxycycline hyclate) ® is a variable dose product dependent on the size, shape, and number of pockets being treated. Preparation for Use 1. If refrigerated, remove the product from refrigeration at least 15 minutes prior to mixing. 2. Couple Syringe A (liquid delivery system) and Syringe B (drug powder). 3. Inject the liquid contents of Syringe A (indicated by red stripe) into Syringe B (doxycycline powder) and then push the contents back into Syringe A. This entire operation is one mixing cycle. 4. Complete 100 mixing cycles at a pace of one cycle per second using brisk strokes. If immediate use is desired, skip to step 7. 5. If necessary, the coupled syringes can be stored at room temperature for a maximum of three days. Some of the Atridox (doxycycline hyclate) systems are packaged in resealable pouches that can be used for this purpose. If the Atridox (doxycycline hyclate) system is packaged in a try, use an airtight container. 6. After storage, perform an additional ten mixing cycles just prior to use. Continue with immediate use instructions. 7. The contents will be in Syringe A (indicated by red stripe). Hold the coupled syringes vertically with Syringe A at the bottom. Pull back on the Syringe A plunger and allow the contents to flow down the barrel for several seconds. 8. Uncouple the two syringes and attach one of the provided cannulae to Syringe A. Product is now ready for application. Product Administration ATRIDOX (doxycycline hyclate) ® does not require local anesthesia for placement. Bend the cannula to resemble a periodontal probe and explore the periodontal pocket in a manner similar to periodontal probing. Keeping the cannula tip near the base of the pocket, express the product into the pocket until the formulation reaches the top of the gingival margin. Withdraw the cannula tip from the pocket. In order to separate the tip from the formulation, turn the tip of the cannula towards the tooth, press the tip against the tooth surface, and pinch the string of formulation from the tip of the cannula. Variations on this technique may be needed to achieve separation between ATRIDOX (doxycycline hyclate) ® and cannula. If desired, using an appropriate dental instrument, ATRIDOX (doxycycline hyclate) ® may be packed into the pocket. Dipping the edge of the instrument in water before packing will help keep ATRIDOX (doxycycline hyclate) ® from sticking to the instrument, and will help speed coagulation of ATRIDOX (doxycycline hyclate) ®. A few drops of water dripped onto the surface of ATRIDOX (doxycycline hyclate) ® once in the pocket will also aid in coagulation. If necessary, add more ATRIDOX (doxycycline hyclate) ® as described above and pack it into the pocket until the pocket is full. Cover the pockets containing ATRIDOX (doxycycline hyclate) ® with either Coe-Pak™ periodontal dressing or a cyanoacrylate dental adhesive. Application of ATRIDOX (doxycycline hyclate) ® may be repeated four months after initial treatment.

Source: http://www.rxlist.com

No information provided. Last reviewed on RxList: 4/11/2011
This monograph has been modified to include the generic and brand name in many instances.

Source: http://www.rxlist.com

ATRIDOX (doxycycline hyclate) ® is indicated for use in the treatment of chronic adult periodontitis for a gain in clinical attachment, reduction in probing depth, and reduction in bleeding on probing.

Source: http://www.rxlist.com

ATRIDOX (doxycycline hyclate) ® should not be used in patients who are hypersensitive to doxycycline or any other drug in the tetracycline class.Last reviewed on RxList: 4/11/2011
This monograph has been modified to include the generic and brand name in many instances.

Source: http://www.rxlist.com

No information provided.

Source: http://www.rxlist.com

The final blended product is 500 mg of formulation containing 50 mg of doxycycline hyclate (doxycycline hyclate, 10%). ATRIDOX (doxycycline hyclate) ® is available as a tray or pouch containing a doxycycline hyclate syringe (50 mg), an ATRIGEL® Delivery System syringe (450 mg), and a blunt cannula. The pouched product is available in a box of six (NDC 63646-191-00) a box of two (NDC63646-191-02), or a professional sample pouch (NDC 63646-191-01). The trayed product is available in a box of six (NDC 63646-191-05), a box of four (NDC 63646-191-04), or a professional sample box of two (NDC 63646-191-03). Each ATRIDOX (doxycycline hyclate) ® syringe system is intended for use in only one patient. Do not use if packaging has been previously opened or damaged. Storage Conditions Store at 2° - 30°C (36° - 86°F). Manufactured by TOLMAR Inc. Fort Collins, CO 80526. Distributed by Zila Therapeutics, Inc. Rev. 02/11. Last reviewed on RxList: 4/11/2011
This monograph has been modified to include the generic and brand name in many instances.

Source: http://www.rxlist.com

General ATRIDOX (doxycycline hyclate) ® has not been clinically tested in pregnant women. ATRIDOX (doxycycline hyclate) ® has not been clinically evaluated in patients with conditions involving extremely severe periodontal defects with very little remaining periodontium. ATRIDOX (doxycycline hyclate) ® has not been clinically tested for use in the regeneration of alveolar bone, either in preparation for or in conjunction with the placement of endosseous (dental) implants or in the treatment of failing implants. ATRIDOX (doxycycline hyclate) ® has not been clinically tested in immunocompromised patients (such as patients immunocompromised by diabetes, chemotherapy, radiation therapy, or infection with HIV). As with other antibiotic preparations, ATRIDOX (doxycycline hyclate) ® therapy may result in overgrowth of nonsusceptible organisms, including fungi.1 The effects of prolonged treatment, greater than 6 months, have not been studied. ATRIDOX (doxycycline hyclate) ® should be used with caution in patients with a history of or predisposition to oral candidiasis. The safety and effectiveness of ATRIDOX (doxycycline hyclate) ® have not been established for the treatment of periodontitis in patients with coexistent oral candidiasis. Carcinogenesis, Mutagenesis, Impairment of Fertility Long-term studies in animals to evaluate carcinogenic potential of doxycycline have not been conducted. However, there has been evidence of oncogenic activity in rats in studies with the related antibiotics, oxytetracycline (adrenal and pituitary tumors), and minocycline (thyroid tumors). Likewise, although mutagenicity studies of doxycycline have not been conducted, positive results in in vitro mammalian cell assays have been reported for related antibiotics (tetracycline, oxytetracycline). Doxycycline administered orally at dosage levels as high as 250 mg/kg/day had no apparent effect on the fertility of female rats. Effect on male fertility has not been studied. Pregnancy Category D. See WARNINGS section Nursing Mothers Tetracyclines appear in breast milk following oral administration. It is not known whether doxycycline is excreted in human milk following use of ATRIDOX (doxycycline hyclate) ® . Because of the potential for serious adverse reactions in nursing infants from doxycycline, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. (See WARNINGS section) Pediatrics The safety and effectiveness of ATRIDOX (doxycycline hyclate) ® in pediatric patients have not been established. Oral doses of doxycycline in children up to 8 years of age have caused permanent discoloration of teeth.Last reviewed on RxList: 4/11/2011
This monograph has been modified to include the generic and brand name in many instances.

Source: http://www.rxlist.com

Health Services in

Drug Database Online

Welcome to Senior Healthcare Matters an online drug guide and dictionary, here you can get drug information and definitaions for most popular pharmaceutical and medicinal drugs, and specifically Atridox. Find what medications you are taking today.